Global Women's Health Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G7198870FD73EN
QYResearch

Abstracts

This report focuses on the global Women's Health status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Women's Health development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Agile Therapeutics
• Allergan
• Amgen
• AstraZeneca
• Bayer AG
• Bristol-Myers Squibb Company
• Ferring
• Merck
• Pfizer
• Teva

Market segment by Type, the product can be split into

• Hormonal Treatment
• Non-Hormonal Treatment

Market segment by Application, split into

• Postmenopausal Osteoporosis
• Infertility
• Endometriosis
• Contraceptives
• Menopause
• Polycystic Ovary Syndrome (PCOS)

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Women's Health status, future forecast, growth opportunity, key market and key players.
• To present the Women's Health development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Women's Health are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Women's Health Revenue
1.4 Market Analysis by Type
  1.4.1 Global Women's Health Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hormonal Treatment
  1.4.3 Non-Hormonal Treatment
1.5 Market by Application
  1.5.1 Global Women's Health Market Share by Application: 2020 VS 2026
  1.5.2 Postmenopausal Osteoporosis
  1.5.3 Infertility
  1.5.4 Endometriosis
  1.5.5 Contraceptives
  1.5.6 Menopause
  1.5.7 Polycystic Ovary Syndrome (PCOS)
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Women's Health Market Perspective (2015-2026)
2.2 Women's Health Growth Trends by Regions
  2.2.1 Women's Health Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Women's Health Historic Market Share by Regions (2015-2020)
  2.2.3 Women's Health Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Women's Health Market Growth Strategy
  2.3.6 Primary Interviews with Key Women's Health Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Women's Health Players by Market Size
  3.1.1 Global Top Women's Health Players by Revenue (2015-2020)
  3.1.2 Global Women's Health Revenue Market Share by Players (2015-2020)
  3.1.3 Global Women's Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Women's Health Market Concentration Ratio
  3.2.1 Global Women's Health Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Women's Health Revenue in 2019
3.3 Women's Health Key Players Head office and Area Served
3.4 Key Players Women's Health Product Solution and Service
3.5 Date of Enter into Women's Health Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Women's Health Historic Market Size by Type (2015-2020)
4.2 Global Women's Health Forecasted Market Size by Type (2021-2026)

5 WOMEN'S HEALTH BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Women's Health Market Size by Application (2015-2020)
5.2 Global Women's Health Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Women's Health Market Size (2015-2020)
6.2 Women's Health Key Players in North America (2019-2020)
6.3 North America Women's Health Market Size by Type (2015-2020)
6.4 North America Women's Health Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Women's Health Market Size (2015-2020)
7.2 Women's Health Key Players in Europe (2019-2020)
7.3 Europe Women's Health Market Size by Type (2015-2020)
7.4 Europe Women's Health Market Size by Application (2015-2020)

8 CHINA

8.1 China Women's Health Market Size (2015-2020)
8.2 Women's Health Key Players in China (2019-2020)
8.3 China Women's Health Market Size by Type (2015-2020)
8.4 China Women's Health Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Women's Health Market Size (2015-2020)
9.2 Women's Health Key Players in Japan (2019-2020)
9.3 Japan Women's Health Market Size by Type (2015-2020)
9.4 Japan Women's Health Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Women's Health Market Size (2015-2020)
10.2 Women's Health Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Women's Health Market Size by Type (2015-2020)
10.4 Southeast Asia Women's Health Market Size by Application (2015-2020)

11 INDIA

11.1 India Women's Health Market Size (2015-2020)
11.2 Women's Health Key Players in India (2019-2020)
11.3 India Women's Health Market Size by Type (2015-2020)
11.4 India Women's Health Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Women's Health Market Size (2015-2020)
12.2 Women's Health Key Players in Central & South America (2019-2020)
12.3 Central & South America Women's Health Market Size by Type (2015-2020)
12.4 Central & South America Women's Health Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Agile Therapeutics
  13.1.1 Agile Therapeutics Company Details
  13.1.2 Agile Therapeutics Business Overview and Its Total Revenue
  13.1.3 Agile Therapeutics Women's Health Introduction
  13.1.4 Agile Therapeutics Revenue in Women's Health Business (2015-2020))
  13.1.5 Agile Therapeutics Recent Development
13.2 Allergan
  13.2.1 Allergan Company Details
  13.2.2 Allergan Business Overview and Its Total Revenue
  13.2.3 Allergan Women's Health Introduction
  13.2.4 Allergan Revenue in Women's Health Business (2015-2020)
  13.2.5 Allergan Recent Development
13.3 Amgen
  13.3.1 Amgen Company Details
  13.3.2 Amgen Business Overview and Its Total Revenue
  13.3.3 Amgen Women's Health Introduction
  13.3.4 Amgen Revenue in Women's Health Business (2015-2020)
  13.3.5 Amgen Recent Development
13.4 AstraZeneca
  13.4.1 AstraZeneca Company Details
  13.4.2 AstraZeneca Business Overview and Its Total Revenue
  13.4.3 AstraZeneca Women's Health Introduction
  13.4.4 AstraZeneca Revenue in Women's Health Business (2015-2020)
  13.4.5 AstraZeneca Recent Development
13.5 Bayer AG
  13.5.1 Bayer AG Company Details
  13.5.2 Bayer AG Business Overview and Its Total Revenue
  13.5.3 Bayer AG Women's Health Introduction
  13.5.4 Bayer AG Revenue in Women's Health Business (2015-2020)
  13.5.5 Bayer AG Recent Development
13.6 Bristol-Myers Squibb Company
  13.6.1 Bristol-Myers Squibb Company Company Details
  13.6.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.6.3 Bristol-Myers Squibb Company Women's Health Introduction
  13.6.4 Bristol-Myers Squibb Company Revenue in Women's Health Business (2015-2020)
  13.6.5 Bristol-Myers Squibb Company Recent Development
13.7 Ferring
  13.7.1 Ferring Company Details
  13.7.2 Ferring Business Overview and Its Total Revenue
  13.7.3 Ferring Women's Health Introduction
  13.7.4 Ferring Revenue in Women's Health Business (2015-2020)
  13.7.5 Ferring Recent Development
13.8 Merck
  13.8.1 Merck Company Details
  13.8.2 Merck Business Overview and Its Total Revenue
  13.8.3 Merck Women's Health Introduction
  13.8.4 Merck Revenue in Women's Health Business (2015-2020)
  13.8.5 Merck Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Women's Health Introduction
  13.9.4 Pfizer Revenue in Women's Health Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 Teva
  13.10.1 Teva Company Details
  13.10.2 Teva Business Overview and Its Total Revenue
  13.10.3 Teva Women's Health Introduction
  13.10.4 Teva Revenue in Women's Health Business (2015-2020)
  13.10.5 Teva Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Women's Health Key Market Segments
Table 2. Key Players Covered: Ranking by Women's Health Revenue
Table 3. Ranking of Global Top Women's Health Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Women's Health Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormonal Treatment
Table 6. Key Players of Non-Hormonal Treatment
Table 7. Global Women's Health Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Women's Health Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Women's Health Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Women's Health Market Share by Regions (2015-2020)
Table 11. Global Women's Health Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Women's Health Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Women's Health Market Growth Strategy
Table 17. Main Points Interviewed from Key Women's Health Players
Table 18. Global Women's Health Revenue by Players (2015-2020) (Million US$)
Table 19. Global Women's Health Market Share by Players (2015-2020)
Table 20. Global Top Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women's Health as of 2019)
Table 21. Global Women's Health by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Women's Health Product Solution and Service
Table 24. Date of Enter into Women's Health Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Women's Health Market Size by Type (2015-2020) (Million US$)
Table 27. Global Women's Health Market Size Share by Type (2015-2020)
Table 28. Global Women's Health Revenue Market Share by Type (2021-2026)
Table 29. Global Women's Health Market Size Share by Application (2015-2020)
Table 30. Global Women's Health Market Size by Application (2015-2020) (Million US$)
Table 31. Global Women's Health Market Size Share by Application (2021-2026)
Table 32. North America Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Women's Health Market Share (2019-2020)
Table 34. North America Women's Health Market Size by Type (2015-2020) (Million US$)
Table 35. North America Women's Health Market Share by Type (2015-2020)
Table 36. North America Women's Health Market Size by Application (2015-2020) (Million US$)
Table 37. North America Women's Health Market Share by Application (2015-2020)
Table 38. Europe Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Women's Health Market Share (2019-2020)
Table 40. Europe Women's Health Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Women's Health Market Share by Type (2015-2020)
Table 42. Europe Women's Health Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Women's Health Market Share by Application (2015-2020)
Table 44. China Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 45. China Key Players Women's Health Market Share (2019-2020)
Table 46. China Women's Health Market Size by Type (2015-2020) (Million US$)
Table 47. China Women's Health Market Share by Type (2015-2020)
Table 48. China Women's Health Market Size by Application (2015-2020) (Million US$)
Table 49. China Women's Health Market Share by Application (2015-2020)
Table 50. Japan Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Women's Health Market Share (2019-2020)
Table 52. Japan Women's Health Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Women's Health Market Share by Type (2015-2020)
Table 54. Japan Women's Health Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Women's Health Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Women's Health Market Share (2019-2020)
Table 58. Southeast Asia Women's Health Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Women's Health Market Share by Type (2015-2020)
Table 60. Southeast Asia Women's Health Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Women's Health Market Share by Application (2015-2020)
Table 62. India Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 63. India Key Players Women's Health Market Share (2019-2020)
Table 64. India Women's Health Market Size by Type (2015-2020) (Million US$)
Table 65. India Women's Health Market Share by Type (2015-2020)
Table 66. India Women's Health Market Size by Application (2015-2020) (Million US$)
Table 67. India Women's Health Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Women's Health Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Women's Health Market Share (2019-2020)
Table 70. Central & South America Women's Health Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Women's Health Market Share by Type (2015-2020)
Table 72. Central & South America Women's Health Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Women's Health Market Share by Application (2015-2020)
Table 74. Agile Therapeutics Company Details
Table 75. Agile Therapeutics Business Overview
Table 76. Agile Therapeutics Product
Table 77. Agile Therapeutics Revenue in Women's Health Business (2015-2020) (Million US$)
Table 78. Agile Therapeutics Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Women's Health Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Product
Table 87. Amgen Revenue in Women's Health Business (2015-2020) (Million US$)
Table 88. Amgen Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Product
Table 92. AstraZeneca Revenue in Women's Health Business (2015-2020) (Million US$)
Table 93. AstraZeneca Recent Development
Table 94. Bayer AG Company Details
Table 95. Bayer AG Business Overview
Table 96. Bayer AG Product
Table 97. Bayer AG Revenue in Women's Health Business (2015-2020) (Million US$)
Table 98. Bayer AG Recent Development
Table 99. Bristol-Myers Squibb Company Company Details
Table 100. Bristol-Myers Squibb Company Business Overview
Table 101. Bristol-Myers Squibb Company Product
Table 102. Bristol-Myers Squibb Company Revenue in Women's Health Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Company Recent Development
Table 104. Ferring Company Details
Table 105. Ferring Business Overview
Table 106. Ferring Product
Table 107. Ferring Revenue in Women's Health Business (2015-2020) (Million US$)
Table 108. Ferring Recent Development
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Company Details
Table 112. Merck Revenue in Women's Health Business (2015-2020) (Million US$)
Table 113. Merck Recent Development
Table 114. Pfizer Company Details
Table 115. Pfizer Business Overview
Table 116. Pfizer Product
Table 117. Pfizer Revenue in Women's Health Business (2015-2020) (Million US$)
Table 118. Pfizer Recent Development
Table 119. Teva Company Details
Table 120. Teva Business Overview
Table 121. Teva Product
Table 122. Teva Revenue in Women's Health Business (2015-2020) (Million US$)
Table 123. Teva Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Women's Health Market Share by Type: 2020 VS 2026
Figure 2. Hormonal Treatment Features
Figure 3. Non-Hormonal Treatment Features
Figure 4. Global Women's Health Market Share by Application: 2020 VS 2026
Figure 5. Postmenopausal Osteoporosis Case Studies
Figure 6. Infertility Case Studies
Figure 7. Endometriosis Case Studies
Figure 8. Contraceptives Case Studies
Figure 9. Menopause Case Studies
Figure 10. Polycystic Ovary Syndrome (PCOS) Case Studies
Figure 11. Women's Health Report Years Considered
Figure 12. Global Women's Health Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Women's Health Market Share by Regions: 2020 VS 2026
Figure 14. Global Women's Health Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Women's Health Market Share by Players in 2019
Figure 17. Global Top Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women's Health as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Women's Health Revenue in 2019
Figure 19. North America Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Agile Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Agile Therapeutics Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 28. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Allergan Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 30. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Amgen Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 34. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bayer AG Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 36. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Company Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 38. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Ferring Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 40. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 44. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Teva Revenue Growth Rate in Women's Health Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed